ATPC.NASDAQAgape Atp CORP

10-K: Agape ATP Corporation Reports Fiscal Year 2023 Results, Revenue Declines Amid Strategic Shift

Sentiment:

Annual Results


Agape ATP Corporation's 2023 annual report reveals a decrease in revenue and a net loss, alongside identified material weaknesses in internal controls.

Capital raiseThe company may need additional capital in the future if it experiences changes in business conditions or other developments.The company may seek to issue equity or debt securities or obtain credit facilities if its cash requirements exceed the amount of cash and cash equivalents it has on hand.
Worse than expectedThe company's revenue decreased by 22.9% year-over-year, indicating worse than expected performance.The company's net loss increased by 26.6% year-over-year, indicating worse than expected financial results.The company's network marketing revenue decreased by 65.2%, indicating worse than expected performance in this segment.

Summary

  • Agape ATP Corporation's revenue decreased by 22.9% to $1.4 million in 2023, compared to $1.9 million in 2022.
  • The company experienced a net loss of $2.1 million in 2023, an increase from the $1.7 million loss in 2022.
  • The decline in revenue was primarily due to a significant decrease in network marketing business revenue, which fell by 65.2%.
  • Revenue from complementary health therapies increased by 44.4%, partially offsetting the decline in network marketing revenue.
  • Gross profit decreased by 21.3% to $0.9 million in 2023, compared to $1.2 million in 2022.
  • The company identified three material weaknesses in its internal control over financial reporting.
  • The company's total assets increased to $5.7 million in 2023, up from $2.8 million in 2022.
  • The company's total liabilities increased to $1.4 million in 2023, up from $1.2 million in 2022.
  • The company repurchased 135,300 shares of its common stock at an average price of $0.69 per share during the year ended December 31, 2023.

Sentiment

Score: 3

Explanation: The document presents a concerning financial picture with declining revenue, increasing losses, and identified internal control weaknesses. While there are some positive aspects, the overall tone is negative from an investment perspective.

Positives

  • The company's total assets increased significantly year-over-year.
  • The company successfully uplisted to the Nasdaq Capital Market.
  • Revenue from complementary health therapies increased by 44.4%, indicating growth in this segment.
  • The company is taking steps to remediate identified material weaknesses in internal controls.

Negatives

  • The company experienced a significant decrease in revenue and an increase in net loss.
  • Network marketing revenue declined substantially, impacting overall performance.
  • The company identified material weaknesses in its internal control over financial reporting.
  • Selling expenses increased significantly due to promotional activities.
  • Commission expenses decreased significantly due to lower network marketing revenue.

Risks

  • The company is heavily reliant on two major suppliers, which poses a risk to product supply.
  • Changes in consumer preferences and spending habits could negatively impact sales.
  • The company may face challenges in protecting its intellectual property rights.
  • Product liability claims or recalls could result in significant losses.
  • The company operates in a heavily regulated industry and may face compliance issues.
  • The company's internal controls may be inadequate, leading to unreliable financial reporting.
  • Legal disputes could divert management's attention and resources.
  • Failure to comply with anti-corruption laws could damage the company's reputation.
  • The company may not be able to manage its growth effectively.
  • The company has a limited operating history, making it difficult to evaluate future prospects.
  • The company's historical growth rates may not be indicative of future growth.
  • The company lacks insurance coverage, which could expose it to significant costs.
  • A decline in general economic conditions could reduce consumer demand.
  • The company may need additional capital, and financing may not be available.
  • Adverse developments in Malaysia could impact the company's operations.
  • Fluctuations in foreign currency exchange rates could affect financial results.
  • The loss of key personnel, such as Mr. How Kok Choong, could severely impact the business.
  • The company may not be able to attract and retain qualified staff.
  • The company faces risks related to health epidemics and other outbreaks.
  • The company operates in a highly competitive market.
  • The company's share price may be volatile and subject to securities litigation.
  • The company may never be able to pay dividends.
  • Shareholders may be diluted through the issuance of securities.
  • The company is a smaller reporting company, which may make its stock less attractive to investors.

Future Outlook

The company anticipates expanding into Asian markets, with a focus on Thailand, Indonesia, and Taiwan, and will explore expansion via e-commerce. The company will also re-assess plans to set up offices in the countries in which it operates to better service its customers.

Management Comments

  • The company is positioning itself for sustainable growth by diversifying its operations into the domain of renewable energy.
  • The company is committed to environmental responsibility, long-term value creation, and proactive adaptation to global energy trends.

Industry Context

The health and wellness market in Malaysia is mature and highly competitive, with numerous companies offering similar products and services. The company's performance is affected by changes in consumer preferences, economic conditions, and regulatory requirements.

Comparison to Industry Standards

  • The company's revenue decline contrasts with the general growth trends observed in the global health and wellness market, which has seen increased consumer spending on health-related products and services.
  • The company's gross profit margin of 65.4% is within the range of other companies in the health and wellness industry, but the decline in revenue and increase in operating expenses have resulted in a net loss.
  • The company's reliance on a network marketing model is similar to some competitors, but the significant decrease in network marketing revenue suggests a need to re-evaluate this strategy.
  • The company's identified material weaknesses in internal controls are a concern, as they indicate a lack of robust financial reporting processes, which is not in line with industry best practices.
  • The company's lack of insurance coverage is not typical for larger, more established companies in the health and wellness sector, which often have product liability and business disruption insurance.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Executive DirectorMohd Shaharuddin Bin AbdullahWilfrendo Fernando Cortizo2023-11-21Resignation of previous director and appointment of new director.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Audit Committee CharterThe company adopted a charter for the Audit Committee pursuant to its IPO.2023-10-11The Audit Committee is responsible for reviewing and making recommendations concerning the selection of outside auditors, reviewing the scope, results and effectiveness of the annual audit of the Companys financial statements and other services provided by the Companys independent public accountants.
Compensation Committee CharterThe company adopted a charter for the Compensation Committee pursuant to its IPO.2023-10-11The Compensation Committee is responsible for overseeing and making recommendations to the board of directors regarding the salaries and other compensation of our executive officers and general employees and providing assistance and recommendations with respect to our compensation policies and practices.
Nominating and Governance Committee CharterThe company adopted a charter for the Nominating and Governance Committee pursuant to its IPO.2023-10-11The Nominating and Corporate Governance Committee responsible for identifying and proposing new potential director nominees to the board of directors for consideration and reviewing our corporate governance policies.

Legal Proceedings

  • There are currently no pending legal proceedings or claims that the company believes will have a material adverse effect on its business, financial condition or operating results.

Related Party Transactions

  • The company has various related party transactions, including purchases from and sales to entities related to its directors and officers.
  • The company acquired approximately 99.99% of the issued share capital of Agape Superior Living Sdn Bhd from Dr. How Kok Choong.
  • Dr. How Kok Choong, our CEO and director, was appointed as the non-executive Chairman of Vettons.
  • There were share forfeiture agreements between the Company and (i) HKC Talent Limited; (ii) various stockholders of the Company.
  • A share forfeiture agreement was entered between the Company and Dr. How Kok Choong.

Stakeholder Impact

  • Shareholders may experience a decrease in the value of their investment due to the company's poor financial performance.
  • Employees may be affected by potential cost-cutting measures or restructuring due to the company's financial challenges.
  • Customers may be impacted by changes in product offerings or service quality due to the company's strategic shift.
  • Suppliers may face uncertainty due to the company's reliance on a few major vendors and potential changes in purchasing patterns.
  • Creditors may be at risk due to the company's increasing liabilities and net losses.

Next Steps

  • The company intends to establish an internal audit function with assessment of Sarbanes-Oxley compliance requirements and improvement of overall internal control.
  • The company intends to initiate a comprehensive training program and development plan to provide ongoing company-wide trainings regarding internal control and requirements of U.S. GAAP financial statements and related disclosures.
  • The company will explore expansion via e-commerce.
  • The company will re-assess plans to set up offices in the countries in which it operates to better service its customers.

Key Dates

DateDescription
2003-08-08Agape Superior Living Sdn. Bhd. incorporated in Malaysia.
2016-06-01Agape ATP Corporation incorporated in Nevada.
2017-03-06Agape ATP Corporation (Labuan) incorporated.
2017-06-01Agape ATP International Holding Limited incorporated in Hong Kong.
2020-05-08Agape ATP Corporation entered into a Share Exchange Agreement to acquire Agape Superior Living Sdn. Bhd.
2020-09-11Wellness ATP International Holdings Sdn, Bhd incorporated in Malaysia.
2021-11-11Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd.
2023-10-11Agape ATP Corporation uplisted to Nasdaq Capital Market.
2023-12-31End of fiscal year 2023.
2024-01-03The Company formed a joint-venture entity, OIE ATPC Holdings (M) Sdn. Bhd.
2024-01-08OIE ATPC Holdings (M) Sdn Bhd formed a wholly own entity, OIE ATPC Exim (M) Sdn Bhd.
2024-03-14The Company acquired 50% of OIE ATPC Holdings (M) Sdn Bhd equity interest from OIE.
2024-03-26Latest practicable date for share information.
2024-04-01Date of the report.

Keywords

Health and Wellness, Network Marketing, Financial Results, Internal Controls, Revenue Decline, Net Loss, Nasdaq, Material Weaknesses, Complementary Health Therapies, Product Supply, Risk Factors

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.